More Insights
Healthcare Delivery and Payers Pharmaceuticals and Medical DevicesChallenges
- Healthcare Delivery and Payers
- Pharmaceuticals and Medical Devices
The Role of Telehealth in an Evolving U.S. Marketplace
Covid-19 led to a surge in the use of telehealth across the U.S. But what’s likely to happen next? Will we see long-term impact on healthcare business models, health outcomes, and consumer expectations about healthcare convenience and access? To understand how industry leaders are thinking about telehealth in light of…
Telehealth After Covid-19 – There’s No Turning Back
Numerof Brief
Well before Covid-19 came on the scene, telehealth had earned its stripes as a cost-effective care delivery and population health platform. Despite numerous benefits, telehealth’s potential was marginalized by the lobbying efforts of hospitals, medical associations, and specialists seeking to defend their turf and the lucrative nature of current fee-for-service…
What’s Causing Providers’ Slow Shift to Value? A Deeply Ingrained Business Model
AJMC
There are myriad reasons why providers have yet to adopt the risk-based arrangements that add value to care delivery, 2 of the latest claims being a lack of adequate data and quality-measure incentives. However, statements like these largely reflect resistance. Most have more data than they realize, and they have…
